Skip to Main Content

U-CH7

General Characteristics

Age: 67 years

Gender: Male

Disease Origin: Sacral

Disease Status: Primary

Prior Radiation: No

Prior Systemic Therapy: No

Source: Silke Bruderlein, Peter Moller, University of Ulm; Adrienne Flanagan, University College London


Molecular Features

Cell Morphology: Physaliferous

TBXT Expression: Positive; 28x that of U-CH2

TBXT Localization: Nuclear

CD24 Expression: Positive; 8x that of U-CH2

HLA Type:

Sequence Data: WGS, Exome and Transcriptome data available: raw sequencing data in Cavatica (Chordoma Foundation Dataset) and summary data in PedcBioportal. Contact researchteam@chordoma.org with any questions.

SMARCB1 Status: Wild-type

Validation Results: Validation Report


Growth Conditions

Growth Medium: (4:1) IMDM/RPMI 1640 + 10% FBS + 1% NEAA + 1% GlutaMAX
Freeze Medium: 70% complete growth medium supplemented with an additional 20% fetal bovine serum and 10% DMSO
Culture Conditions:Temperature: 37°C
Atmosphere: air, 95%; carbon dioxide (CO2), 5%

Subculturing Instructions:

Cell Culture Procedures


Publications

Characterized By:

  • Not yet published